Alzheimer’s disease drug
C7048
concept
An Alzheimer’s disease drug is a pharmacological agent designed to prevent, slow, or alleviate the cognitive and functional decline associated with Alzheimer’s pathology, typically by targeting amyloid, tau, neurotransmitter systems, or related neurodegenerative mechanisms.
All labels observed (3)
| Label | Occurrences |
|---|---|
| NMDA receptor antagonist | 2 |
| Alzheimer’s disease drug canonical | 1 |
| Alzheimer’s disease therapy candidate | 1 |
Instances (4)
| Instance | Via concept surface |
|---|---|
|
memantine
surface form:
Memantine
|
NMDA receptor antagonist |
| amantadine | NMDA receptor antagonist |
| Leqembi | — |
| bapineuzumab | Alzheimer’s disease therapy candidate |